Production (Stage)
Anika Therapeutics, Inc.
ANIK
$11.24
-$0.53-4.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.87M | -- | -29.92M | -88.00K | -4.51M |
| Total Depreciation and Amortization | 1.59M | -- | 2.19M | 2.06M | 2.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.42M | -- | 31.25M | 5.00M | 6.50M |
| Change in Net Operating Assets | -269.00K | -- | 1.49M | -8.04M | -4.18M |
| Cash from Operations | -130.00K | -- | 5.02M | -1.07M | -126.00K |
| Capital Expenditure | -2.82M | -- | -1.22M | -3.40M | -1.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.50M | -- | -600.00K | -- | -- |
| Cash from Investing | 1.67M | -- | -1.82M | -3.40M | -1.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 464.00K | 23.00K |
| Repurchase of Common Stock | -5.44M | -- | -3.99M | -1.58M | -2.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.44M | -- | -3.99M | -1.11M | -2.27M |
| Foreign Exchange rate Adjustments | 108.00K | -- | 337.00K | -224.00K | -31.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.79M | -- | -454.00K | -5.81M | -4.24M |